Baker Avenue Asset Management, LP

Position in VCEL — Vericel Corp

CIK 1432529 SAN FRANCISCO, CA

Position in VCEL

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,166,483

+$329,581 QoQ

Shares Held

26,219

+0.8% QoQ

Ownership

0.051%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#126

of 315 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Baker Avenue Asset Management, LP holds $4,381,815 across 10 Biotechnology names. VCEL ranks #1 (26.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VCEL	Vericel Corp This page	26,219	$1,166,483
2	PCVX	Vaxcyte, Inc.	13,279	$771,908
3	JAZZ	Jazz Pharmaceuticals plc	2,447	$589,653
4	REGN	Regeneron Pharmaceuticals, Inc.	931	$580,515
5	RPRX	Royalty Pharma plc	6,991	$391,985
6	VRTX	Vertex Pharmaceuticals Inc / Ma	653	$324,364
7	INCY	Incyte Corp	2,148	$243,497
8	EXEL	Exelixis, Inc.	3,885	$211,382

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,166,483	26,219	+0.8%	Shares	Sole	2026-07-28
2026-03-31	$836,902	26,015	-9.5%	Shares	Sole	2026-05-12
2025-12-31	$1,035,071	28,744	0.0%	Shares	Sole	2026-02-10
2025-09-30	$904,573	28,744	0.0%	Shares	Sole	2025-10-31
2025-06-30	$1,223,057	28,744	0.0%	Shares	Sole	2025-08-13
2025-03-31	$1,282,557	28,744	-33.5%	Shares	Sole	2025-05-08
2024-12-31	$2,373,429	43,224	-2.2%	Shares	Sole	2025-02-14
2024-09-30	$1,866,900	44,187	+24.0%	Shares	Sole	2024-11-04
2024-06-30	$1,635,392	35,645	-0.3%	Shares	Sole	2024-08-08
2024-03-31	$1,859,454	35,745	-0.1%	Shares	Sole	2024-05-13
2023-12-31	$1,274,303	35,785	-7.8%	Shares	Sole	2024-02-15
2023-09-30	$1,300,576	38,800	—	Shares	Sole	2023-11-15
No filing history on record for this holder in this stock.